OZK heads into its October 22 earnings report carrying one of the heaviest short positions in the regional banking sector, a fresh round of analyst target cuts, and a stock price that has shed 6.5% over the past month.
The short position is the defining feature of this setup. Short interest has climbed to 14.6% of the free float, with 16.45 million shares borrowed. That is up 1.9% over the week and has been drifting higher since early September, when it was closer to 15.4 million shares. The ORTEX short score sits at 67.1, near the top of its recent range. For context, days-to-cover is estimated at 17.6 based on the most recent FINRA fortnightly data, which means any significant buying pressure would take time to work through the borrow. That said, the lending market itself is not under stress. Availability is running at roughly 774% of short interest, down slightly from 829% a week ago but still well above even the year's tightest level of 280%. Cost to borrow is just 0.49%, low and barely moving. The message from the borrow market is that plenty of shares remain available to short without friction, so the elevated short interest reflects genuine bearish conviction rather than a squeeze setup.
Options positioning reinforces the cautious read. The put/call ratio is running at 1.64, just above its 20-day average of 1.63 and close to the middle of its recent range. This is not a sharp defensive spike, but it reflects a market that has been systematically reaching for put protection since early September, when the ratio was closer to 1.3. The PCR has not been this structurally elevated since mid-year, and the pattern has coincided almost exactly with the stock's decline from above $49.
The Street has turned more negative this week. Wells Fargo cut its target from $56 to $51 on September 30, maintaining an Equal-Weight rating. That follows Morgan Stanley's September 8 downgrade to Underweight from Equal-Weight, with the target subsequently nudged up marginally to $57 on September 28, an unusual move that kept the bearish rating while lifting the number. The mean analyst target is $54.56, which implies roughly 18% upside to the current price of $46.20. But that headline figure masks a growing camp of sceptics. TD Cowen dropped from Buy to Hold in July. The trend in analyst action has been one of rating compression: targets are being cut, not raised, and the directional bias is toward caution. The valuation picture adds nuance. OZK trades at 7.7 times earnings and below book value at 0.78 times, both levels that bulls argue are too cheap for a bank generating a 1.75% return on assets. The dividend yield factor ranks in the 83rd percentile. Bears counter that real estate credit risk, particularly in construction and land development, could push nonperforming assets higher and compress net interest margins if rates move unfavourably.
Retail attention is worth a note in passing. Wikipedia page views for Bank OZK are running at a z-score of 2.1 against the stock's own 90-day history, the highest signal from the alt-data layer. That points to elevated retail interest in the name at a moment when institutional flows are mixed. BlackRock added 159,000 shares through to end-August, and Charles Schwab and American Century both added meaningfully. But Vanguard Portfolio Management trimmed nearly 156,000 shares in the June quarter. Wasatch Advisors, whose 13G filing from July shows its stake has dropped from 5.5% to 4.2%, has been a steady seller. Peers UCB, AUB, and HWC all fell between 1.7% and 1.9% on the week, closely matching OZK's 1.7% decline, suggesting the move is sector-wide rather than stock-specific.
The four prior earnings prints all saw the stock fall on the day, averaging roughly a 1% drop at the open, with five-day moves close to flat. With the Q3 report due October 22, the question will be less about whether short sellers are right about credit stress and more about whether loan growth and NII guidance for 2027 can shift the narrative that has kept 14.6% of the float sold short.
See the live data behind this article on ORTEX.
Open OZK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
